Skip to content
CA.gov logo in white
  • Grants Management System
  • CIRM Hub Portal
  • Contact
  • About
    • Our Mission
    • Our Impact
    • Our Governing Board
    • Strategic Goals
    • Our Team
    • Annual Reports
  • For Researchers
    • Funding Opportunities
    • Information for Applicants
    • Researcher Resources
    • Our Review Process
  • Our Programs
    • Grants Dashboard
    • Research and Development
    • Education and Training
    • Patient Access
  • Patient Resources
    • Stem Cell and Genetic Research
    • From Bench to Bedside
    • Community Outreach
    • CIRM Clinical Trials
    • Community Stories
  • News and Events
    • Press Releases
    • Public Meetings
    • Blog
    • Webinars and Workshops
  • About
    • Our Mission
    • Our Impact
    • Our Governing Board
    • Strategic Goals
    • Our Team
    • Annual Reports
  • For Researchers
    • Funding Opportunities
    • Information for Applicants
    • Researcher Resources
    • Our Review Process
  • Our Programs
    • Grants Dashboard
    • Research and Development
    • Education and Training
    • Patient Access
  • Patient Resources
    • Stem Cell and Genetic Research
    • From Bench to Bedside
    • Community Outreach
    • CIRM Clinical Trials
    • Community Stories
  • News and Events
    • Press Releases
    • Public Meetings
    • Blog
    • Webinars and Workshops

Recombinant Bispecific Antibody Targeting Cancer Stem Cells for the Therapy of Glioblastoma

  • Post author:
  • Post published:July 1, 2025
  • Post category:

Glioblastoma multiforme is the most prevalent and aggressive type of brain tumor, and devastating to any patient unfortunate enough to receive its diagnosis. As the most populous state in the…

Continue ReadingRecombinant Bispecific Antibody Targeting Cancer Stem Cells for the Therapy of Glioblastoma

A monoclonal antibody that depletes blood stem cells and enables chemotherapy free transplants

  • Post author:
  • Post published:July 1, 2025
  • Post category:

Successful stem cell therapy requires replacement of diseased or dysfunctional stem cells with healthy ones. These healthy stem cells can come from either a donor or can be stem cells…

Continue ReadingA monoclonal antibody that depletes blood stem cells and enables chemotherapy free transplants

Anti-Notch1, OMP-52M51: A New Cancer Therapeutic to Reduce CSC Frequency

  • Post author:
  • Post published:July 1, 2025
  • Post category:

A important benefit of the tremendous progress in stem cell research has been the recognition that stem cell pathways are frequently re-activated in cancer cells conferring stem cell-like properties on…

Continue ReadingAnti-Notch1, OMP-52M51: A New Cancer Therapeutic to Reduce CSC Frequency

Genetically Engineered Mesenchymal Stem Cells for the Treatment of Vertebral Compression Fractures.

  • Post author:
  • Post published:July 1, 2025
  • Post category:

Osteoporosis is an unsolved and highly prevalent health care problem: 10 million Americans suffer from the disease, and an additional 34 million have low bone mass. Roughly half of all…

Continue ReadingGenetically Engineered Mesenchymal Stem Cells for the Treatment of Vertebral Compression Fractures.

Neuroprotection to treat Alzheimer’s: a new paradigm using human central nervous system cells

  • Post author:
  • Post published:July 1, 2025
  • Post category:

Alzheimer’s disease (AD) is an incurable disorder that affects memory, social interaction and the ability to perform everyday activities. In the USA alone, the number of AD patients aged 65…

Continue ReadingNeuroprotection to treat Alzheimer’s: a new paradigm using human central nervous system cells

Combination therapy to Enhance Antisense Mediated Exon Skipping for Duchenne Muscular Dystrophy

  • Post author:
  • Post published:July 1, 2025
  • Post category:

A drug was identified through the use of muscle stem cells that can enhance the effectiveness of exon skipping by antisense oligonucleotides to the DMD gene to restore dystrophin expression…

Continue ReadingCombination therapy to Enhance Antisense Mediated Exon Skipping for Duchenne Muscular Dystrophy

Preclinical Development and First-In-Human Testing of GRNCM1 in Advanced Heart Failure

  • Post author:
  • Post published:July 1, 2025
  • Post category:

This application seeks to bring to the clinic a new treatment for myocardial disease based on human embryonic stem cell (hESC) derived cardiomyocytes. hESC-cardiomyocytes have the unique potential to address…

Continue ReadingPreclinical Development and First-In-Human Testing of GRNCM1 in Advanced Heart Failure

Neural Stem Cell-Based Therapy For Parkinson’s Disease

  • Post author:
  • Post published:July 1, 2025
  • Post category:

Ongoing degeneration of dopaminergic (DA) neurons in the midbrain is the hallmark of Parkinson’s disease (PD), a movement disorder that manifests with tremor, bradykinesia and rigidity. One million Americans live…

Continue ReadingNeural Stem Cell-Based Therapy For Parkinson’s Disease

Increasing the endogenous mesenchymal stem cells to the bone surface to treat osteoporosis

  • Post author:
  • Post published:July 1, 2025
  • Post category:

Although most individuals are aware that osteoporosis is disease of increased bone fragility that results from estrogen deficiency and aging, most are unaware of the high risk and cost of…

Continue ReadingIncreasing the endogenous mesenchymal stem cells to the bone surface to treat osteoporosis

hESC-derived NPCs Programmed with MEF2C for Cell Transplantation in Parkinson’s Disease

  • Post author:
  • Post published:July 1, 2025
  • Post category:

We proposes to use human embryonic stem cells (hESCs) differentiated into neural progenitor/stem cells (NPCs), but modified by transiently programming the cells with the transcription factor MEF2C to drive them…

Continue ReadinghESC-derived NPCs Programmed with MEF2C for Cell Transplantation in Parkinson’s Disease
  • Go to the previous page
  • 1
  • …
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • Go to the next page
  • Careers
  • Administrative & Financials
  • Accessibility

Subscribe to Receive CIRM News

Get the latest CIRM news, information on upcoming meetings, and funding opportunities delivered to your inbox. 

Sign Up
Facebook-f X-twitter Instagram Linkedin Youtube
  • Privacy Policy
  • ©2025 California Institute for Regenerative Medicine
  • Media Guidelines
  • Contact Us